Moderna Gets FDA Nod for First mRNA Flu Vaccine

Moderna's mFlusiva just earned FDA approval, making it the first mRNA-based flu shot on the US market. This follows EU approval earlier this year for their combined flu and COVID-19 vaccine. It's a big step for mRNA tech beyond COVID-19, potentially changing how we think about annual vaccines.